BioMarin Pharmaceutical
BMRN
#1818
Rank
S$14.57 B
Marketcap
S$75.86
Share price
-2.32%
Change (1 day)
-17.89%
Change (1 year)

BioMarin Pharmaceutical (BMRN) Fails to deliver data

Key failure to deliver metrics for BioMarin Pharmaceutical:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioMarin Pharmaceutical (BMRN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioMarin Pharmaceutical (BMRN) - since 2013

Volume in USD (price x number of shares), data since 2013

BioMarin Pharmaceutical (BMRN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025S$13.1 M-48.16%
2024S$25.28 M-2.78%
2023S$26 M-3.87%
2022S$27.05 M-24.36%
2021S$35.76 M-61.48%
2020S$92.85 M217.25%
2019S$29.26 M-60.68%
2018S$74.43 M66.59%
2017S$44.68 M-18.44%
2016S$54.78 M-33.54%
2015S$82.43 M51.23%
2014S$54.5 M57.97%
2013S$34.5 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Ultragenyx Pharmaceutical
RARE
S$1.09 MS$6.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.43 MS$8.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$4.99 MS$10.48 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.8 MS$69.68 M๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
S$8.41 MS$14.56 M๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$0.17 MS$0.95 M๐Ÿ‡บ๐Ÿ‡ธ USA